SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 147 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 5.41 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $306,459 | -32.5% | 11,688 | -33.8% | 0.14% | -62.2% |
| Q1 2023 | $454,234 | -49.8% | 17,647 | -49.3% | 0.37% | -31.1% |
| Q4 2022 | $905,226 | +146.0% | 34,803 | +170.0% | 0.54% | +155.7% |
| Q3 2022 | $368,000 | -21.7% | 12,888 | -32.5% | 0.21% | -26.1% |
| Q2 2022 | $470,000 | +7.3% | 19,080 | +146.0% | 0.28% | +2.2% |
| Q1 2022 | $438,000 | -60.5% | 7,755 | -56.6% | 0.28% | -68.5% |
| Q4 2021 | $1,108,000 | +12.0% | 17,870 | +14.6% | 0.88% | +34.9% |
| Q3 2021 | $989,000 | +12.9% | 15,594 | +46.7% | 0.65% | +5.3% |
| Q2 2021 | $876,000 | +23.2% | 10,631 | +9.9% | 0.62% | +17.6% |
| Q1 2021 | $711,000 | -21.0% | 9,669 | -22.1% | 0.53% | -8.2% |
| Q4 2020 | $900,000 | +64.5% | 12,412 | +8.1% | 0.58% | +44.1% |
| Q3 2020 | $547,000 | +22.4% | 11,477 | +7.8% | 0.40% | +7.8% |
| Q2 2020 | $447,000 | – | 10,649 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 3,081,307 | $79,313 | 9.91% |
| Finepoint Capital LP | 614,231 | $15,810,306 | 6.04% |
| M28 Capital Management LP | 197,700 | $5,088,798 | 5.75% |
| Boxer Capital, LLC | 3,421,541 | $88,070 | 4.33% |
| Deep Track Capital, LP | 3,100,000 | $79,794,000 | 3.28% |
| EcoR1 Capital, LLC | 3,460,208 | $89,065,754 | 2.87% |
| Artal Group S.A. | 1,817,349 | $46,779 | 2.78% |
| Orbimed Advisors | 4,498,900 | $115,801,686 | 2.27% |
| Perceptive Advisors | 2,079,352 | $53,522,520 | 1.58% |
| SPHERA FUNDS MANAGEMENT LTD. | 317,625 | $8,175,668 | 1.37% |